Search
Bionano Genomics Inc
BNGOAdd to Watchlist
1.150USD
-0.020-1.71%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
12.35MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Bionano Genomics Inc is 8.00, ranking 67 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 7.50, with a high of 8.00 and a low of 7.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
5.000
Target Price
+327.35%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
3
Median
6
Average
Company name
Ratings
Analysts
Bionano Genomics Inc
BNGO
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Bionano Genomics Inc's expected revenue for the next quarter?
Bionano Genomics Inc's expected revenue is 7.48M.
What is Bionano Genomics Inc's price target?
Analysts forecast that Bionano Genomics Inc's price target is USD 7.50, with the highest forecast at USD 8.00 and the lowest forecast at USD 7.00.
How have Bionano Genomics IncBNGO's recent earnings per share performed?
The market expectation was USD -0.76, while Bionano Genomics IncBNGO's earnings per share (EPS) for the previous quarter was USD -0.77. EPS for the next quarter is expected at USD -0.69.
What is the analyst rating for Bionano Genomics Inc?
Based on the ratings of Bionano Genomics Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.